KLRC1 and graft versus host disease: Among the EBV reactivation and EBV-chronic graft-versus-host disease (GvHD) patients after hematopoietic stem cell transplantation (HSCT), the frequency of NKG2A+CD56dim NK cells was significantly increased in peripheral blood (92).